Andrew Grage
Reviews 1

I recently had the pleasure of coming across a remarkable biotechnology company that truly exceeded my expectations. From the moment I visited their website, I was extremely impressed with the professionalism and user-friendly interface. The information provided was comprehensive and easy to understand, making it effortless to learn about their innovative solutions. What really sets this company apart is their commitment to research and development. Their cutting-edge technology and molecular conjugation platforms are revolutionizing the field. The dedication and expertise of their team shines through in everything they do. Additionally, their customer support is exceptional. They responded promptly to my inquiries and went above and beyond to ensure my needs were met. The level of service I received was truly exemplary. In conclusion, this company is an outstanding player in the biotechnology industry. Their website is informative, their solutions are groundbreaking, and their customer service is top-notch. I highly recommend them to anyone in need of advanced biotechnology solutions.

Andrew Girvan
Reviews 1

I recently had the pleasure of working with a company and I must say that I am impressed. The products they offer are of great quality and their customer service is top-notch. I would definitely recommend them to anyone in need of their services.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="synaffix-bv" data-lang="en"></div>
More widgets

About Synaffix bv

Synaffix BV is a clinical-stage, Netherlands-based biotech company that has established a proprietary antibody-drug conjugate (ADC) technology platform that enhances efficacy and tolerability compared to all 3 major clinical-stage ADC technologies. We have a 'one-stop' technology offering (including 4 different ADC payloads) that enables the development of proprietary ADCs from any antibody and our patent portfolio provides patent protection of resulting Products through at least 2035. Our business model is technology out-licensing and we regularly engage in research collaborations with other companies that are interested in developing highly competitive ADC products for their own pipelines. Disclosed partnerships to date include those with ADC Therapeutics and Mersana Therapeutics

Categories
Biotechnology